Oncovir
Business Services · District of Columbia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3203 Cleveland Ave NW, Washington, Distr...Phone Number
(202) 342-1726Website
www.oncovir.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Oncovir
Oncovir, Inc. is a Clinical Phase Biotechnology company focused on developing Hiltonol (Poly ICLC) as a drug product and vaccine adjuvant for oncology and infectious diseases. The company aims to activate both innate and adaptive immunity to enhance treatment outcomes. Their innovative approach includes combining poly-ICLC with immunotherapy vaccines, particularly for challenging conditions like brain cancer. Oncovir targets healthcare providers and researchers in the fields of cancer and infectious disease treatment.Explore more
Oncovir Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oncovir your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Oncovir
Oncovir, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Oncovir launches new products
Check out if Oncovir is spiking on competitors!
Funding: Get notified immidiatlly once Oncovir has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Oncovir has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Oncovir recently announced quarterly report
Click to see if Oncovir had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Oncovir
Find 3 more new buyers
Compare Similar Companies to Oncovir
Compare insights from companies similar to Oncovir, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Oncovir is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Oncovir is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Oncovir.
Oncovir financials insights
Gather financial insights about Oncovir, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$80K
Oncovir Tech Stack
A closer look at the technologies used by Oncovir
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oncovir
Sign Up For FreeTo access detailed company insights
Oncovir, Inc. is a Clinical Phase Biotechnology company focused on developing Hiltonol (Poly ICLC) as a drug product and vaccine adjuvant for oncology and infectious diseases. The company aims to activate both innate and adaptive immunity to enhance treatment outcomes. Their innovative approach includes combining poly-ICLC with immunotherapy vaccin... Read More
